
Eli Lilly CEO calls Amodei’s disease-cure timeline unlikely
Dave Ricks said biology is still largely unmapped and human proof, not model forecasts, is the long pole in drug development.
1 stories, newest first · one card per story

Dave Ricks said biology is still largely unmapped and human proof, not model forecasts, is the long pole in drug development.
Today 904 readers · 989 views · 97 reads · all time 215K views